Glazer Capital, LLC 13D and 13G filings for Inozyme Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-04 5:09 pm Purchase |
2025-05-28 | 13G | Inozyme Pharma, Inc. INZY |
Glazer Capital, LLC | 4,251,940 6.590% |
4,251,940 (New Position) |
Filing |